Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 8 studies | 43% ± 24% | |
myeloid cell | 8 studies | 28% ± 17% |
Insufficient scRNA-seq data for expression of MMP9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 96% | 1700.66 | 557 / 578 | 82% | 105.24 | 947 / 1155 |
breast | 56% | 647.66 | 258 / 459 | 80% | 162.31 | 889 / 1118 |
skin | 40% | 100.68 | 726 / 1809 | 71% | 142.70 | 335 / 472 |
intestine | 35% | 215.06 | 334 / 966 | 69% | 60.69 | 364 / 527 |
spleen | 100% | 8027.10 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 42% | 150.26 | 276 / 653 | 56% | 42.03 | 339 / 605 |
lymph node | 0% | 0 | 0 / 0 | 97% | 807.71 | 28 / 29 |
peripheral blood | 93% | 35145.34 | 866 / 929 | 0% | 0 | 0 / 0 |
stomach | 19% | 90.13 | 70 / 359 | 72% | 66.63 | 207 / 286 |
tonsil | 0% | 0 | 0 / 0 | 91% | 131.91 | 41 / 45 |
adipose | 84% | 1169.17 | 1006 / 1204 | 0% | 0 | 0 / 0 |
uterus | 12% | 36.40 | 21 / 170 | 68% | 129.24 | 314 / 459 |
esophagus | 11% | 39.55 | 158 / 1445 | 68% | 64.59 | 125 / 183 |
pancreas | 3% | 6.42 | 10 / 328 | 73% | 59.32 | 130 / 178 |
bladder | 14% | 42.43 | 3 / 21 | 57% | 63.65 | 285 / 504 |
ovary | 7% | 35.98 | 12 / 180 | 57% | 51.99 | 247 / 430 |
liver | 34% | 135.50 | 77 / 226 | 25% | 16.73 | 103 / 406 |
kidney | 30% | 135.69 | 27 / 89 | 25% | 21.20 | 229 / 901 |
prostate | 14% | 33.76 | 35 / 245 | 22% | 8.67 | 112 / 502 |
heart | 27% | 94.15 | 235 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 27% | 452.28 | 362 / 1335 | 0% | 0 | 0 / 0 |
brain | 7% | 16.21 | 195 / 2642 | 19% | 19.09 | 137 / 705 |
eye | 0% | 0 | 0 / 0 | 14% | 6.52 | 11 / 80 |
adrenal gland | 7% | 17.45 | 18 / 258 | 7% | 8.99 | 15 / 230 |
muscle | 5% | 11.15 | 38 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
GO_2001268 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_1900122 | Biological process | positive regulation of receptor binding |
GO_0150077 | Biological process | regulation of neuroinflammatory response |
GO_0030225 | Biological process | macrophage differentiation |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0030198 | Biological process | extracellular matrix organization |
GO_2000697 | Biological process | negative regulation of epithelial cell differentiation involved in kidney development |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_1904645 | Biological process | response to amyloid-beta |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0030574 | Biological process | collagen catabolic process |
GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0051549 | Biological process | positive regulation of keratinocyte migration |
GO_0006508 | Biological process | proteolysis |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_2001258 | Biological process | negative regulation of cation channel activity |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006915 | Biological process | apoptotic process |
GO_0001501 | Biological process | skeletal system development |
GO_2001243 | Biological process | negative regulation of intrinsic apoptotic signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0071492 | Biological process | cellular response to UV-A |
GO_0016477 | Biological process | cell migration |
GO_0007566 | Biological process | embryo implantation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005518 | Molecular function | collagen binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MMP9 |
Protein name | Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9] |
Synonyms | CLG4B |
Description | FUNCTION: Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration . Could play a role in bone osteoclastic resorption (By similarity). Cleaves KiSS1 at a Gly-|-Leu bond . Cleaves NINJ1 to generate the Secreted ninjurin-1 form . Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments . Degrades fibronectin but not laminin or Pz-peptide. . |
Accessions | P14780 ENST00000372330.3 |